⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADAG News
Adagene Inc. American Depositary Shares
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology
globenewswire.com
ADAG
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates
globenewswire.com
ADAG
EXEL
Adagene to Participate in Three Upcoming Investor Conferences
globenewswire.com
ADAG
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates
globenewswire.com
ADAG
Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
businesswire.com
ADAG
ASTS
Adagene to Participate in Two Upcoming Investor Conferences
globenewswire.com
ADAG
Global Stem Cell Therapy Market Set to Flourish at a CAGR of ~11% by 2034 Owing to the Technological Advancements and Favorable Regulations | DelveInsight
globenewswire.com
ADAG
ABBV
BIIB
BMRN
BLRX
CNSP
CYCN
GEN
GILD
GRAF
GSK
HSIC
HUBS
IBIO
INCY
JAZZ
JNJ
MAGN
MARA
MRK
NVS
OMER
PFE
PRGS
REGN
RGNX
SRPT
TENB
TGLS
TGTX
TNDM
TXG
VRTX
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
globenewswire.com
ADAG
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
globenewswire.com
ADAG
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs
globenewswire.com
ADAG